Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial
Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial
Laurens Manning, Tom Snelling, Okhee Yoo, Jonathan Rhys Carapetis et al.
Citations
2 citations
Journal
The Lancet Microbe
Topics
Streptococcal Infections and Treatments
Field-Weighted Citation Impact (FWCI)
3.76
article
Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial
Laurens Manning, Tom Snelling, Okhee Yoo, Jonathan Rhys Carapetis, Alma Fulurija, Sam Salman, Renae K. Barr, Joshua Osowicki, Kristy Azzopardi, Kevin T. Batty, Joseph Kado, Thel K. Hla, James McCarthy, Lara Hatchuel, Madhu Page‐Sharp, Andrew C. Steer, Stephanie Enkel, Julie Marsh, Michael Morici
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet MicrobeVol. 6(5)
Institutions
The University of Sydney (AU), Royal Children's Hospital (AU), The Kids Research Institute Australia (AU), Walter and Eliza Hall Institute of Medical Research (AU), Curtin University (AU), Peter Doherty Institute (AU), Murdoch Children's Research Institute (AU), Linear Clinical Research (AU), Pathwest Laboratory Medicine (AU)